secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zenas BioPharma, Inc. (ZBIO)
CIK:        0001953926
Form:       8-K
Filed at:   2025-12-15T23:59:59+00:00
Accession:  0001104659-25-121182
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zenas BioPharma adopts 2026 Inducement Plan for up to 1M shares for new hires
-----------------------------------------------------------------------------

- Plan reserves 1,000,000 shares of common stock for equity awards to new employees as hiring inducements.
- Approved Dec 10, 2025 by Board; requires Compensation Committee or independent director approval per Nasdaq Rule 5635(c)(4).
- Plan exempt from stockholder approval; grants include non-statutory stock options, SARs, RSUs, and restricted stock.
- Eligible individuals are new hires or rehires after a bona fide break in employment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1953926/000110465925121182/0001104659-25-121182-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1953926/000110465925121182/tm2533427d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-121182

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer